ArticlePhysical and engineering sciences in medicine2025
Evaluating Monaco 6.2.2 in complex radiotherapy across matched LINACs: improved MLC modelling and dose accuracy with virtual source model 2.0.
Article in Physical and engineering sciences in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study assesses the updated Monaco TPS virtual source model (VSM) 2.0, which removes multileaf collimator (MLC) and jaw characterization as editable factors from the MLC geometry section within Monaco. The focus is on the impact of changes to stereotactic radiotherapy (SRT) cases for spinal and intracranial treatments for two beam matched linear accelerators. A validated custom VSM 1.6 model optimized for SRT was compared with the Elekta Accelerated Go Live 6 MV flattening filter-free (FFF) and VSM 2.0. Evaluations included measured MLC characteristics with a high-resolution detector, measured output factors (OPF), ion chamber fields in the thorax phantom, and recalculations of clinically relevant SRT cases. VSM 2.0 improves MLC modelling. Ion chamber measurements for IAEA TD1583 measurements were found to be within expected tolerances. Gamma pass rates for two matched LINACs evidenced improvement at 1%, 1 mm and 10% threshold for single and multi-SRS brain and SABR Spine treatments. VSM 2.0 represents a meaningful advancement in beam modelling within a Monte Carlo-based TPS environment, offering improved dosimetric performance and operational simplicity. Commercially available detectors were used to demonstrate that VSM 2.0 enhances agility MLC modelling, supporting more precise SRT and SABR delivery for matched LINACs. Removing configurable dependencies from the beam model will result in more consistent high quality beam models, an improves workflows for commissioning of the Monaco TPS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.